×î×¼µÄÁùºÏ²ÊÂÛ̳

XClose

×î×¼µÄÁùºÏ²ÊÂÛ̳ News

Home
Menu

'Game-changing’ Alzheimer’s drug lecenemab rejected by EU

29 July 2024

“This conservative approach means that patients and doctors eager to explore a proven effective drug are now denied access," explains Professor Bart De Strooper (×î×¼µÄÁùºÏ²ÊÂÛ̳ Queen Square Institute of Neurology).

, , , , ,